이식 진단 시장 규모, 점유율 및 성장 분석 : 기술별, 제품·서비스별, 용도별, 이식 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Transplant Diagnostics Market size was valued at USD 4.87 Billion in 2024 and is poised to grow from USD 5.25 Billion in 2025 to USD 9.58 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The Transplant Diagnostics market is experiencing robust growth, driven by heightened demand for organ transplantation and continuous advancements in diagnostic technologies. The prevalence of chronic diseases contributing to organ failures further fuels this growth. As the necessity for precise and efficient transplant compatibility testing escalates, the market is poised for further expansion, enhancing patient outcomes and transplant success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML), which streamline the analysis of extensive data sets, encompassing genomic and clinical information. These technologies enable the identification of patterns and prediction of compatibility, ultimately optimizing organ allocation. Their implementation promises to significantly improve the accuracy and efficiency of transplant diagnostics, thus maximizing resource utilization and patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transplant Diagnostics Market Segments Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transplant Diagnostics Market

The increasing incidence of chronic illnesses, including end-stage renal disease, heart failure, and liver cirrhosis, is a significant factor contributing to the demand for organ transplants. These serious medical conditions frequently necessitate transplantation to enhance patients' quality of life and health outcomes. Additionally, rising awareness among patients and healthcare providers regarding the advantages of organ transplantation has further amplified the need for transplant diagnostics. This heightened focus on compatibility testing between donors and recipients has created opportunities for advancements in this field, ultimately driving the expansion of the transplant diagnostics market as stakeholders seek accurate and efficient solutions.

Restraints in the Transplant Diagnostics Market

The Transplant Diagnostics market faces significant restraints due to the imbalance between the high demand for organ transplants and the limited availability of suitable organs. This scarcity results in extended waiting lists for patients, heightening the risk of mortality or disease progression during the wait. The shortage of organs not only limits the number of transplant procedures but also constrains the market potential for related diagnostic products and services. Furthermore, ethical issues, legal regulations, and cultural attitudes towards organ donation in various regions further exacerbate the organ shortage, thereby hindering the growth and advancement of the transplant diagnostics sector.

Market Trends of the Transplant Diagnostics Market

A significant market trend in the transplant diagnostics industry is the growing integration of advanced technologies such as next-generation sequencing (NGS), which is transforming the landscape of donor-recipient matching. This innovative approach facilitates high-throughput genetic profiling, allowing for comprehensive analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. NGS enhances precision in matching by identifying a broader spectrum of HLA alleles and unveiling rare variants, thus driving more accurate and informed transplant decisions. This technological advancement not only streamlines the diagnostic process but also holds the promise of improved transplant outcomes, ultimately reducing the incidence of graft rejection and maximizing long-term graft survival rates.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Molecular Assay Technologies
  • Pcr-Based Molecular Assays
  • Real-Time Pcr
  • Sequence-Specific Primer-Pcr
  • Sequence-Specific Oligonucleotide-Pcr
  • Other Pcr-Based Molecular Assays
• Sequencing Based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing Based Molecular Assays
• Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostic Application
  • Pre-Transplantation Diagnostics
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
  • Post -Transplantation Diagnostics
• Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2026-2033)

• Market Overview
• Solid Organ Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals And Transplant Centers
• Research & Academic Institutes
• Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2026-2033)

• North America (Technology, Product & Service, Application, Transplant Type, End User)
  • USA
  • Canada
• Europe (Technology, Product & Service, Application, Transplant Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, Transplant Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omixon Ltd. (Estonia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenuix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations